Antithrombotic agents and effect on outcomes in ischemic stroke with atrial fibrillation and large artery atherosclerosis: a real-world study
This study demonstrated that OAC monotherapy was associated with a lower risk for composite outcomes and death after ischemic stroke due to AF and atherosclerotic stenosis, although the OAC dose had no effect on clinical outcomes.
Authors
- Zheng Zhang (ORCID: https://orcid.org/0000-0003-0865-4175)
- Yuntao Liu (ORCID: https://orcid.org/0000-0003-4033-2133)
- Yanlei Zhang (ORCID: https://orcid.org/0000-0003-1536-386X)
- Jianhua Cheng
- Qiang Ye
- J. J. Chen
Institutions
- Wenzhou Medical University (CN)
- First Affiliated Hospital of Wenzhou Medical University (CN)
Publication Details
- Journal
- Frontiers in Neurology
- Published
- 2025-06-09
- DOI
- https://doi.org/10.3389/fneur.2025.1576250
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00